Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004614615 | SCV005102514 | uncertain significance | not specified | 2024-05-30 | criteria provided, single submitter | clinical testing | The c.2523C>A (p.D841E) alteration is located in exon 20 (coding exon 20) of the AXL gene. This alteration results from a C to A substitution at nucleotide position 2523, causing the aspartic acid (D) at amino acid position 841 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |